What is the evidence to support the use of plasma exchange as first‐line therapy for N‐methyl d‐aspartate receptor antibody encephalitis?

Publisher： John Wiley & Sons Inc

E-ISSN： 1098-1101|33|1|126-127

ISSN： 0733-2459

Source： JOURNAL OF CLINICAL APHERESIS, Vol.33, Iss.1, 2018-02, pp. : 126-127

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Intravenous methylprednisolone versus therapeutic plasma exchange for treatment of anti‐n‐methyl‐d‐aspartate receptor antibody encephalitis: A retrospective review

By  

JOURNAL OF CLINICAL APHERESIS, Vol. 30, Iss. 4, 2015-08 ,pp. : 212-216

John Wiley & Sons Inc

Access to resources Recommend Favorite

N‐methyl‐d‐aspartate receptor antibody encephalitis: how much treatment is enough?

By  

DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Vol. 57, Iss. 1, 2015-01 ,pp. : 14-15

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intrathecal treatment of anti‐N‐Methyl‐d‐aspartate receptor encephalitis in children

By  

DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Vol. 57, Iss. 1, 2015-01 ,pp. : 95-99

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anti–N‐methyl‐D‐aspartate receptor encephalitis with multiphasic demyelination

By  

ANNALS OF NEUROLOGY, Vol. 76, Iss. 3, 2014-09 ,pp. : 462-464

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serum complement levels in anti‐N‐methyl‐d‐aspartate receptor encephalitis

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 25, Iss. 1, 2018-01 ,pp. : 178-184

John Wiley & Sons Inc

Access to resources Recommend Favorite